Xsolis

Xsolis announced a leadership change on October 27, 2026. Xsolis appointed former R1 RCM and Cloudmed CEO Lee Rivas as chief executive, succeeding co-founder Joan Butters, who had led the AI-driven mid-revenue cycle technology company since 2013.

What changed

Lee Rivas was named Chief Executive Officer. Joan Butters, CEO and Co-Founder, who had led Xsolis since 2013, was succeeded by Rivas.

• Leader: Lee Rivas
• Role: Chief Executive Officer
• Effective: Effective immediately
• Announcement date: October 27, 2026

Leadership background

Rivas was Chief Executive Officer of Cloudmed, a revenue cycle technology company, where he led the company through a period of rapid growth and its acquisition by R1 RCM, and then led R1 as Chief Executive Officer through its take-private transaction. Earlier, he spent 14 years at RELX as Division President at LexisNexis Risk Solutions and Elsevier and began his career at McKinsey and Company. He is a graduate of the United States Military Academy at West Point and holds an MBA from Harvard Business School.

The mandate

The announcement did not list specific priorities for Rivas. In the release, Butters said she was confident Rivas will keep challenging the industry to break from the status quo that compounds waste in healthcare.

Why this matters for GTM teams

Executive appointments can precede changes in strategy, operating cadence, hiring, partnerships, and technology priorities. The useful signal is not the title alone: teams should watch the new leader’s stated mandate, prior playbook, organizational scope, and the initiatives announced during the first two quarters.

Source and methodology

This leadership profile is based on the company’s announcement. Roles, transition timing, and biographical details are presented as announced; SalesTools Research does not infer undisclosed succession plans.

Primary source: Xsolis leadership announcement.